Table 1 Baseline characteristics (all-subjects-treated population [n = 82])
Sugammadex (n = 46) | Neostigmine (n = 36) | |
|---|---|---|
Gender | ||
Female, n (%) | 29 (63) | 15 (42) |
Male, n (%) | 17 (37) | 21 (58) |
Mean (SD) age, years | 50 (14) | 57 (12) |
Mean (SD) weight, kg | 86 (19) | 86 (18) |
Mean (SD) height, cm | 170 (11) | 173 (10) |
Race, n (%) | ||
Asian | 1 (2) | 3 (8) |
Black (of African heritage) | 6 (13) | 1 (3) |
Caucasian | 38 (83) | 32 (89) |
Other | 1 (2) | 0 |
ASA class, n (%) | ||
1 | 6 (13) | 1 (3) |
2 | 34 (74) | 22 (61) |
3 | 6 (13) | 13 (36) |
4 | 0 | 0 |